3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
7
Colorectal Neoplasms
3
Lung Neoplasms
2
Stomach Neoplasms
1
Peripheral Nervous System Diseases
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Diseases
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Cancer Cachexia
1
Cachexia
1
Breastcancer
1
Biliary Tract Neoplasms
1
Interventions
Megestrol Acetate
7
Exercise
6
Standard of Care
4
Blood Specimen Collection
4
Olanzapine
3
Ibuprofen
3
dermcidin
2
Resistance Training
2
Physical Therapy Modalities
2
Nutrition Assessment
2
Mirtazapine
2
Melatonin
2
Enteral Nutrition
2
Diet Therapy
2
Cyproheptadine
2
testosterone enanthate
1
telotristat ethyl
1
remune
1
olanzapine-fluoxetine combination
1
nabiximols
1
nabilone
1
irinotecan sucrosofate
1
fucoidan
1
bermekimab
1
anamorelin
1
Vitamin D
1
Ultrasonography
1
Retrospective Studies
1
Radiotherapy
1
Powders
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cachexia
×
Omacor
×
Clear all
NCT04907864
2021-06-01
MIRACLE
Kyunghee University Medical Center
Phase 2
Unknown
112 enrolled